Mouse |
Transgenic line, TH-MYCN
|
Human MYCN
|
Thoracic, abdominal, metastasis to lung, liver, ovaries |
CGH, histopathology |
[126] |
Compound transgenic line, TH-MYCN, TH-ALKF1174L
|
Human ALK F1174L plus MYCN
|
Sympathetic ganglia or adrenals, locally invasive |
Immunohistochemistry, transcriptomic |
[98] |
Compound conditional transgenic line, LSL-Lin28b, Dbh-iCre
|
Mouse Lin28b plus Cre
|
Sympathetic ganglia or adrenals |
Bioluminescence imaging, qRT-PCR, immunohistochemistry |
[49] |
Xenograft in immune-deficient mice |
Human MYCN-amplified primary tumor |
Tumors engrafted into kidney capsule |
Cell staining, qRT-PCR, testing NVP-BEZ235 treatment |
[94] |
Compound conditional knockout line, TH-MYCN; TH-Cre, Caspase 8
|
Human MYCN plus loss of mouse Caspase 8
|
Sympathetic ganglia, metastasis to bone marrow |
Immunohistochemistry, microarray, qRT-PCR |
[101] |
Compound knock-in (KI), TH-MYCN; KI Alk
|
Human MYCN plus mouse Alk
|
Multifocal tumors, locally invasive |
Immunohistochemistry, in vivo drug testing, transcriptomic |
[99] |
Immune deficient, CB17SC-M scid−/−
|
Transplantation of human neuroblastoma cells |
Subcutaneously injected tumor cells |
In vivo preclinical drug testing |
[129] |
Zebrafish |
Compound transgenic line, DβH-MYCN, DβH-ALKF1174L
|
Human MYCN plus human ALKF1174L
|
Adrenal, locally invasive |
Immunohistochemistry, in situ hybridization, in vivo imaging |
[102] |
Compound knockout line, nf1a−/−; DβH-MYCN
|
Human MYCN plus loss of zebrafish nf1
|
Adrenal, sympathoadrenal cells |
In vivo imaging, immunohistochemistry, testing trametinib and isotretinoin |
[128] |
Immunocompromised rag2E45°fs
|
Transplantation of zebrafish neuroblastoma cells overexpressing Human MYCN and ALKF1174L
|
Observation of tumor development and metastasis |
In vivo imaging, flow cytometry, immunohistochemistry |
[130,131] |
Transparent, roy−/−; nacre−/− “Casper”
|
Transplantation of human tumor cells |
Observation of tumor development and metastasis |
In vivo imaging with resolution down to single cells |
[131,132] |
Drosophila melanogaster
|
Transgenic |
Various targets involved in stem cell division |
Understanding stem cell-like qualities of neuroblastoma tumors |
Immunohistochemistry, tumor karyotyping, asymmetric cell division |
[134,135] |